KAITLYN TYNDALL: Open Payments
NPI 1700560653 · CLINTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$779 in 36 payments from 9 companies in 2025. Trend: 2023 $83 · 2024 $387 · 2025 $779
Food & beverage: $779
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $287 |
| Amgen Inc. | 9 | $184 |
| Lilly USA, LLC | 8 | $132 |
| ANI Pharmaceuticals, Inc. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
| Astellas Pharma US Inc | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $15 |
Products named: Ozempic, REPATHA, MOUNJARO, Wegovy, PURIFIED CORTROPHIN GEL, OTEZLA, AIRSUPRA, ZEPBOUND.
Industry payments across NC — which companies pay providers there.
